Ennature Biopharma

Activities: Manufacturing Ingredients Active Nutrition

Ennature Biopharma, a division of India Glycols Limited (IGL), is a leading manufacturer of science-backed, plant-based ingredients for the nutraceutical and pharmaceutical industries. As a part of IGL—a publicly listed pioneer in green technology with an annual turnover exceeding USD 800 million—Ennature Biopharma is committed to delivering innovative, sustainable solutions that promote healthy living.

Visit website

Profile

Harnessing nature through innovation

Grounded in the principles of Nature, Technology, and Innovation, Ennature Biopharma specialises in the development and production of complex phytopharmaceutical and nutraceutical actives. Our proprietary technology platforms, LIMAN™ and SCEMOD™, enable the creation of high-efficacious plant-based ingredients. 

Our team of over 30 in-house scientists works on different research platforms like phytochemistry, analytical research and development, pharmacology, toxicology, biotechnology, formulation development, etc., to curate effective, natural health solutions that meet global standards. We maintain a fully traceable, backward-integrated supply chain for biomass sourcing. Our commitment to quality is demonstrated through global accreditations, including U.S. FDA, WHO-GMP, ISO 9001, ISO 22000, HACCP, Halal, and Kosher certifications.

Clinically validated ingredient portfolio 

Ennature Biopharma

Maxicuma® is a clinically studied, clean label ingredient from turmeric, standardised to 40% curcuminoids that helps improve joint pain, stiffness, mobility and physical performance at an ultra-low dose of 100-250mg/day. Formulated with proprietary technology platform, LIMAN™ (Lecithin based Liposomal Microencapsulation), Maxicuma® exhibits enhanced solubility delivering 172 folds higher levels of free curcumin in the human blood plasma than conventional curcumin extract, facilitating better absorption and the bio efficacy thereof.

Ennature Biopharma

Xanthogreen® is a clean label ingredient from marigold flowers that has been clinically studied to help boost your eye health with visible effects in as little as Week 4 onwards. Formulated with proprietary technology platform, SCEMOD™ (Super Critically Enabled Molecular Optimal Dispersion) facilitating better absorption and the bio efficacy thereof. Xanthogreen® exhibits enhanced solubility by 1000X - up to 20%, compared to conventional lutein, which is only 0.02%.

Ennature Biopharma

Gingeren® is an ultra-low dose ingredient standardised to 20% total gingerols, developed using sustained release technology for enhanced half-life by 5x, along with enhanced overall tolerability. Gingeren® is clinically studied to improve the general health of menstruating women, promoting an active lifestyle.

For more information on our complete product portfolio visit us at https://www.ennaturebiopharma.com/ or write to us: ennature@indiaglycols.com

Social Media

LinkedIn

Youtube

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    TurtleTree's precision-fermented lactoferrin gets the FDA green light TurtleTree’s gut and immune health-supporting lactoferrin ingredient, LF+, can now be freely included in functional foods, beverages and supplements within the US
  2. ACG debuts personalised capsule manufacturing technology for precision supplements The PCM allows supplement brands to manufacture bespoke supplement formulations based on individual biomarkers, lifestyle choices and health goals
  3. Lycored's Lumenato to be deemed a Novel Food by the EFSA The carotenoid-rich nutraceutical has been proven to support skin health by protecting it from UV exposure and collagen degradation
  4. Egg-less baking: the rise of faba bean protein With consumers reducing their consumption of eggs from industrial farming, the bakery industry is embracing egg alternatives
  5. Gelita to focus on concepts for protein fortification at HiE Bioactive collagen peptides, as well as special types of gelatin, play an important role in the development of dietary supplements

Upcoming event

2025 Update: FDA Dietary Supplements Oversight

6 June 2025 | Virtual See all

Related Content

Manufacturing

Ennature Biopharma’s Maxicuma and Xanthogreen achieve Clean Label Project certification

Ennature Biopharma’s Maxicuma and Xanthogreen achieve Clean Label Project certification, reinforcing its commitment to purity and transparency
Ingredients

New study confirms ultra-low dose curcumin extract significantly reduced symptoms of joint discomfort

Maxicuma, a patented turmeric ingredient, improved physical function in participants by 97%
Ingredients

Study reveals benefits of Ennature Biopharma's turmeric ingredient

A group of researchers have carried out an open label study on the curcumin levels of Ennature Biopharma's turmeric ingredient Maxicuma
Subscribe now